Abstract
By applying the acetyl-CoA-carboxylase inhibitors soraphen A (SorA) and coenzyme A (CoA) ex vivo, we aimed to reduce proinflammatory cytokine release ......
小提示:本篇文献需要登录阅读全文,点击跳转登录